Structure | Chemical Name | CAS | MF |
|
1H,5H-Cyclopenta[f]pyrido[1,2-c][1,3]oxazepine,decahydro-,(3a-alpha-,10a-bta-,11a-bta-)-(9CI)
|
142751-28-8
|
C12H21NO
|
|
2,4,6-TRIMETHYLPHENYLGLYOXAL HYDRATE
|
142751-35-7
|
C11H14O3
|
|
1-(4-aminophenyl)piperidin-4-ol
|
142752-12-3
|
C11H16N2O
|
|
METHYL-PHENETHYL-PIPERIDIN-4-YL-AMINE
|
142752-20-3
|
C14H22N2
|
|
2-(N-METHYL-2-AMINOETHYL)-1,3-DIOXOLANE
|
142753-10-4
|
C6H13NO2
|
|
8-CHLOROADENOSINE-3',5'-CYCLIC MONOPHOSPHOROTHIOATE, RP-ISOMER SODIUM SALT
|
142754-27-6
|
C10H11ClN5O5PS
|
|
8-CHLOROADENOSINE-3',5'-CYCLIC MONOPHOSPHOROTHIOATE, SP-ISOMER SODIUM SALT
|
142754-28-7
|
C10H10ClN5NaO5PS
|
|
5,6-DIMETHYL-1-BETA-D-RIBOFURANOSYLBENZIMIDAZOLE-3',5'-CYCLIC MONOPHOSPHATE,SODIUM SALT
|
142754-31-2
|
C14H16N2NaO6P
|
|
eudistalbin A
|
142755-07-5
|
C16H18BrN3
|
|
11-ketofistularin 3
|
142755-09-7
|
C31H28Br6N4O11
|
|
Silanediol, [(dimethylamino)methyl]- (9CI)
|
142756-08-9
|
C3H11NO2Si
|
|
Oxiranecarboxylic acid, 3-[(ethylamino)carbonyl]-, (2S,3S)- (9CI)
|
142759-58-8
|
C6H9NO4
|
|
pseudoprototimosaponin AIII
|
142759-74-8
|
C45H74O18
|
|
D-MYO-INOSITOL 4-MONOPHOSPHATE AMMONIUM SALT
|
142760-33-6
|
C6H16NO9P
|
|
(1,2-bis(2-hydroxyphenyl)ethylenediamine)dichloroplatinum (II)
|
142760-38-1
|
C14H14Cl2N2O2Pt
|
|
R-(-)-O-DESMETHYLVENLAFAXINE
|
142761-11-3
|
C16H25NO2
|
|
S-(+)-O-DESMETHYL VENLAFAXINE
|
142761-12-4
|
C16H25NO2
|
|
(3-(1-(triisopropylsilyl)-5-(triMethylsilyl) penta-1,4-diyn-3-ylidene)penta-1,4-diyne- 1,5-diyl)bis(triisopropylsilane)
|
142761-77-1
|
C40H72Si4
|
|
(3-(1-(triisopropylsilyl)penta-1,4-diyn- 3-ylidene)penta-1,4-diyne-1,5- diyl) bis(triisopropylsilane)
|
142761-78-2
|
C37H64Si3
|
|
(R)-2-CHLORO-1-(3-CHLOROPHENYL)ETHANOL
|
142763-10-8
|
C8H8Cl2O
|
|
3,3′,5,5′-Tetramethyl-4,4′-diphenoquinone (TMDQ)
|
142763-32-4
|
C16H16O2
|
|
NSC 640865
|
142763-37-9
|
C20H24O3
|
|
1-CBZ-2-PROPYL-PIPERIDIN-4-ONE
|
142764-70-3
|
C16H21NO3
|
|
2-(4-methoxyphenyl)-5-((4-methylpiperazin-1-yl)-3H-imidazo(4,5-b)pyridin-2-yl)-3H-imidazo(4,5-b)pyridine
|
142764-75-8
|
C24H24N8O
|
|
1,1,2-TRIBROMOPENTAFLUOROCYCLOBUTANE
|
142764-86-1
|
C4Br3F5
|
|
coat protein, peanut stripe virus
|
142767-66-6
|
|
|
5,6-DIMETHOXY-1H-INDOLE-3-CARBALDEHYDE
|
142769-27-5
|
C11H11NO3
|
|
1-Chloro-4-propoxythioxanthone
|
142770-42-1
|
C16H13ClO2S
|
|
(2'S,3S)-1-(2-METHYLAMINO-2-PHENYL-ETHYL)-PYRROLIDIN-3-OL
|
142773-73-7
|
C13H20N2O
|
|
ETHYL 1-(2-FURYLMETHYL)-4,5-DIOXOPYRROLIDINE-3-CARBOXYLATE
|
142774-43-4
|
C12H13NO5
|
|
2,5-Diazabicyclo[2.2.1]heptane, 1-methyl-2-(trifluoroacetyl)-, (1R)- (9CI)
|
142776-10-1
|
C8H11F3N2O
|
|
1-Imidazolidineacetamide, alpha-(2,2-dimethyl-1-oxopropyl)-N-[2-methoxy-5-[(1-oxooctadecyl)amino]phenyl]-2,5dioxo-3-(phenylmethyl)
|
142776-95-2
|
C42H62N4O6
|
|
Diethyl (2-iodoethyl)phosphonate
|
142778-06-1
|
C6H14IO3P
|
|
3-Pyridinecarboxylicacid,6-(acetylamino)-1,2,5,6-tetrahydro-5-hydroxy-,(5S-trans)-(9CI)
|
142779-94-0
|
C8H12N2O4
|
|
Pyrazineethanol, 5,6-dimethyl- (9CI)
|
142780-04-9
|
C8H12N2O
|
|
4-acetylaplykurodin B
|
142780-49-2
|
C22H34O4
|
|
aplykurodinone B
|
142780-50-5
|
C20H30O3
|
|
3-Bromo-4-chloro-8-methoxyquinoline
|
142781-92-8
|
C10H7BrClNO
|
|
Methyl 5-amino-4H-1,2,4-triazole-3-carboxylate hydrochloride
|
142782-22-7
|
C4H6N4O2.ClH
|
|
N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
|
142784-25-6
|
C23H23N9O4
|
|
N-ACETOXY-PHIP
|
142784-27-8
|
C15H14N4O2
|
|
bis(di-n-butyl(4-aminosalicylate)tin)oxide
|
142785-14-6
|
|
|
bis(diphenyl(4-aminosalicylate)tin)oxide
|
142785-15-7
|
|
|
20-(3-hydroxy-3-methylbutyloxy)pregna-5,7-diene-1,3-diol
|
142785-61-3
|
C26H42O4
|
|
4-Hepten-2-one, 5,6-dimethyl-, (E)- (9CI)
|
142787-70-0
|
C9H16O
|
|
4-Hepten-2-one, 5,6-dimethyl-, (Z)- (9CI)
|
142787-76-6
|
C9H16O
|
|
1-(3-Chlorophenyl)-4-hydroxymethyl-7,8-dimethoxy-5H-2,3-benzodiazepine
|
142790-94-1
|
|
|
Oxandrolone USP IMpurity B
|
142793-21-3
|
C19H28O2
|
|
2,3:5,6-DI-O-ISOPROPYLIDENE-4-(4-METHOXY-TETRAHYDROPYRAN-4-YL)-MYO-INOSITOL
|
142795-23-1
|
C18H30O8
|
|
1H,5H-Cyclopenta[f]pyrido[1,2-c][1,3]oxazepine,decahydro-,(3a-alpha-,10a-alpha-,11a-bta-)-(9CI)
|
142796-06-3
|
C12H21NO
|
|
Isosilybin A
|
142796-21-2
|
C25H22O10
|
|
(2R,3R)-3,5,7-Trihydroxy-2-[(2S,3S)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydrobenzo[1,4]dioxin-6-yl]-4-chromanone
|
142796-22-3
|
C25H22O10
|
|
D-Proline, 4-(acetyloxy)-, trans- (9CI)
|
142796-93-8
|
C7H11NO4
|
|
4-Cyclohexene-1,2,3-triol,6-amino-,[1R-(1alpha,2alpha,3beta,6alpha)]-(9CI)
|
142796-97-2
|
C6H11NO3
|
|
4-Cyclohexene-1,2,3-triol,6-amino-,[1S-(1alpha,2alpha,3beta,6alpha)]-(9CI)
|
142797-00-0
|
C6H11NO3
|
|
Bicyclo[2.2.1]heptan-2-ol, 3-(dimethylamino)-, [1S-(endo,endo)]- (9CI)
|
142797-14-6
|
C9H17NO
|
|
METHYL 2,3,4-TRI-O-BENZYL-BETA-D-GLUCURONIC ACID, BENZYL ESTER
|
142797-33-9
|
C35H36O7
|
|
SILYBIN (A and B)(P)
|
142797-34-0
|
C25H22O10
|
|
1-cyclopropyl-4-phenyl-1,2,3,6-tetrahydropyridine
|
142798-22-9
|
|
|
4-cyclopropyl-2-phenyl-2-butene
|
142798-24-1
|
C13H17N
|
|
4-cyclopropyl-1-methyl-1,2,3,6-tetrahydropyridine
|
142798-26-3
|
|
|
6,6'-DI-O-(TERT-BUTYLDIMETHYLSILYL)-D-LACTAL
|
142800-37-1
|
C24H48O9Si2
|
|
1-Isoquinolineacetic acid,1,2,3,4-tetrahydro-6-methoxy-,1,1-dimethylethyl ester,(S)- (9CI)
|
142801-72-7
|
C16H23NO3
|
|
3'-azido-3',5'-dideoxythymidine-5'-methylphosphonic acid diphosphate
|
142802-35-5
|
C11H21N6O12P3
|
|
VapA protein
|
142805-17-2
|
|
|
HTF9-C protein
|
142805-30-9
|
|
|
CCAAT-enhancer-binding protein-epsilon
|
142805-41-2
|
|
|
Tris(4-(thiophen-2-yl)phenyl)aMine
|
142807-63-4
|
C30H21NS3
|
|
4-Bromo-2-fluorobenzotrifluoride
|
142808-15-9
|
C7H3BrF4
|
|
agelasine G
|
142808-37-5
|
C31H42BrN6O2+
|
|
1,1-Dimethyl-4-oxo-3,5-bis(3-phenyl-2-propenylidene)piperidinium iodid e
|
142808-59-1
|
|
|
Clinopodiside A
|
142809-89-0
|
C48H78O19
|
|
2-((2S,3S)-2-(((9H-fluoren-9-yl)Methoxy)carbonylaMino)-3-MethylpentanaMido)acetic acid
|
142810-18-2
|
C23H26N2O5
|
|
Fmoc-Val-Gly-OH
|
142810-19-3
|
C22H24N2O5
|
|
Cyclohexanecarboxamide,N-(4-chlorophenyl)-
|
142810-49-9
|
C13H16ClNO
|
|
4-N-benzoylgeMcitabine
|
142816-70-4
|
C16H15F2N3O5
|
|
2,4,6-TRIS(1-CHLOROETHYL)-1,3,5-TRIOXANE
|
142817-71-8
|
C9H15Cl3O3
|
|
1-phenyl-3-(trifluoromethyl)pyrazole-4-carboxylic acid
|
142818-01-7
|
C11H7F3N2O2
|
|
1-(TERT-BUTYL)-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID
|
142818-02-8
|
C9H11F3N2O2
|
|
1-(4-NITROPHENYL)-5-(TRIFLUOROMETHYL)PYRAZOLE-4-CARBOXYLIC ACID
|
142818-03-9
|
C11H6F3N3O4
|
|
N-(4-acetylphenyl)-2-oxo-2H-chromene-3-carboxamide
|
142818-76-6
|
C18H13NO4
|
|
1-Pyrrolidinecarboxylic acid, 3-propyl-, methyl ester
|
142819-46-3
|
C9H17NO2
|
|
5-methyl-17-fluoroheptadecanoic acid
|
142820-18-6
|
|
|
Butanamide, N-(2-oxopentyl)-
|
142821-34-9
|
C9H17NO2
|
|
D-Proline, 4-hydroxy-2-methyl-, ethyl ester, trans- (9CI)
|
142824-25-7
|
C8H15NO3
|
|
bombesin(6-14), Tpi(6)-Leu(13)-psi(CH2N)-Tpi(14)-
|
142824-94-0
|
C62H78N16O9
|
|
L-Sulforaphane
|
142825-10-3
|
C6H11NOS2
|
|
(2,7-OCTADIEN-1-YL)SUCCINIC ANHYDRIDE
|
142826-45-7
|
C12H16O3
|
|
5-[(2-CHLOROETHYL)THIO]-1,3,4-THIADIAZOLE-2-THIOL
|
142826-71-9
|
C4H5ClN2S3
|
|
5-oxo-15-hydroxy-6,8,11,13-eicosatetraenoic acid
|
142828-12-4
|
C20H30O4
|
|
2H-Pyrimido[5,4-e]-1,3-oxazine (9CI)
|
142834-76-2
|
C6H5N3O
|
|
2-(2,3-DIMETHYLPHENOXY)PROPANOHYDRAZIDE
|
142835-36-7
|
C11H16N2O2
|
|
2-Aziridinecarboxylicacid,1-methoxy-3-methyl-,methylester,trans-(9CI)
|
142835-68-5
|
C6H11NO3
|
|
(3-exo)-3-Amino-8-(phenylmethyl)-8-azabicyclo[3.2.1]octane-3-carbonitrile
|
142838-94-6
|
C15H19N3
|
|
BETA-METHYL-BETA-NITRO-4'-(TRIFLUOROMETHYL)STYRENE
|
142840-01-5
|
C10H8F3NO2
|
|
Diltiazem N-Oxide
|
142843-04-7
|
C22H26N2O5S
|
|
bisphenol A/ isophthalic acid/ adipic acid polymer
|
142843-99-0
|
C35H44O12
|
|
Refractories, fibers, aluminosilicate
|
142844-00-6
|
Al6O13Si2
|
|
M-cadherin
|
142845-03-2
|
C14H13N3S
|
|
xP4 protein
|
142845-14-5
|
|